NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $141.84 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$14.42B
CountryUSA
RECENT INSIDER TRADES
2026-09-15 · Boyer David W. (Chief Corp. Affairs Officer) · SELL
2026-09-15 · ABERNETHY MATT (Chief Financial Officer) · SELL
2026-09-15 · Keswani Sanjay Chandru (Chief Medical Officer) · OTHER
2026-09-15 · Gano Kyle (Chief Executive Officer) · OTHER
2026-09-15 · Lippoldt Darin (Chief Legal Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders838
Shares held128,387,981
Value$20.25B
Percent of shares outstanding126.30%
As of quarter end2026-06-30
RECENT NEWS
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
Neurocrine Biosciences appoints Eiry W. Roberts as Chief Medical Officer
Neurocrine Biosciences presents at Morgan Stanley Global Healthcare Conference